Nebula Research & Development’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,300	Closed	-$461K	–	938
2024 Q1	$461K	Buy	+6,300	New	+$461K	0.1%	382
2023 Q4	–	Sell	-5,379	Closed	-$322K	–	777
2023 Q3	$322K	Buy	+5,379	New	+$322K	0.17%	258